THE EFFECT OF CYCLOSPORINE AND LIVER AUTOTRANSPLANTATION ON BILE FLOW AND COMPOSITION IN DOGS1,2
CLINICAL COURSE, MORPHOLOGY, AND TREATMENT OF CHRONICALLY REJECTING SMALL BOWEL ALLOGRAFTS
SUCCESSFUL INTRACEREBROVENTRICULAR ALLOTRANSPLANTATION OF PARATHYROID TISSUE IN RATS WITHOUT IMMUNOSUPPRESSION1
THE EFFECT OF PROTEASE INHIBITOR ON REPERFUSION INJURY AFTER UNILATERAL PULMONARY ISCHEMIA
ESSENTIAL FATTY ACID DEFICIENCY INCREASES INTERSTITIAL IA-POSITIVE CELLS IN RAT KIDNEY AND ACCELERATES RENAL ALLOGRAFT REJECTION1
ABSENCE OF TOLERANCE TO NONINHERITED MATERNAL TRANSPLANTATION ANTIGENS EXPRESSED ON SKIN AND CORNEA1
THE EFFECT OF HEPATIC ISCHEMIA-REPERFUSION ON POLYAMINE METABOLISM IN SOME ORGANS OF THE RAT
HEPATITIS C—ITS PREVALENCE IN END-STAGE RENAL FAILURE PATIENTS AND CLINICAL COURSE AFTER KIDNEY TRANSPLANTATION
A POSSIBLE ROLE FOR SPECIFIC “ANERGY” IN IMMUNOLOGIC HYPOREACTIVITY TO DONOR STIMULATION IN HUMAN KIDNEY ALLOGRAFT RECIPIENTS1
TYPE III HYPERLIPOPROTEINEMIA ACQUIRED BY LIVER TRANSPLANTATION
EXPERIENCE WITH FK506 IN LIVING-RELATED LIVER TRANSPLANTATION
ADULT RESPIRATORY DISTRESS SYNDROME SECONDARY TO END-STAGE LIVER DISEASE—SUCCESSFUL OUTCOME FOLLOWING LIVER TRANSPLANTATION1
RAPID DETECTION OF ANTI-OKT3 ANTIBODIES WITH THE TRANSTAT ASSAY1
DILTIAZEM IN RENAL ALLOGRAFT RECIPIENTS RECEIVING CYCLOSPORINE
TREATMENT OF GROWTH FAILURE IN CHILDREN AFTER RENAL TRANSPLANTATION1
HEMOSTATIC CHANGES IN HEART TRANSPLANT RECIPIENTS AND THEIR RELATIONSHIP TO ACCELERATED CORONARY SCLEROSIS
ANALYSIS OF INFLAMMATORY ENDOTHELIAL CHANGES, INCLUDING VCAM-1 EXPRESSION, IN MURINE CARDIAC GRAFTS1,2
EVIDENCE THAT I-E-NEGATIVE MICE RESISTANT TO NEONATAL H-2 TOLERANCE INDUCTION DISPLAY UBIQUITOUS THYMIC CLONAL DELETION OF DONOR-REACTIVE T CELLS1
PRODUCTION OF CYTOKINES (TNF-ALPHA, IL-1-BETA) AND ENDOTHELIAL CELL ACTIVATION IN HUMAN LIVER ALLOGRAFT REJECTION1
THE MORPHOLOGY AND FUNCTION OF RABBIT HEPATOCYTES ISOLATED USING ETHYLENEDIAMINETETRAACETATE1
THE RELATIONSHIP OF BLOOD CONCENTRATIONS OF RAPAMYCIN AND CYCLOSPORINE TO SUPPRESSION OF ALLOGRAFT REJECTION IN A RABBIT HETEROTOPIC HEART TRANSPLANT MODEL1
EVIDENCE THAT CYCLOSPORINE CAUSES BOTH INTRACELLULAR MIGRATION AND INAPPROPRIATE URINARY EXCRETION OF MAGNESIUM IN RATS1
PROTECTION OF ISLETS OF LANGERHANS FROM ANTIBODIES BY MICROENCAPSULATION WITH ALGINATE-POLY-L-LYSINE MEMBRANES1
CHARACTERIZATION OF MATURATION AND FUNCTION OF NATURAL KILLER CELLS IN XENOGENEIC (RAT ± MOUSE) BONE MARROW CHIMERAS
THE ASSESSMENT OF TRANSPLANTATION TOLERANCE INDUCED BY ANTI-CD4 MONOCLONAL ANTIBODY IN THE MURINE MODEL1
SUPPRESSION OF GRAFT-VERSUS-HOST DISEASE BY SUCCINYL ACETONE IN A RAT ALLOGENEIC BONE MARROW TRANSPLANTATION MODEL
SPECIFIC UNRESPONSIVENESS IN RATS WITH PROLONGED CARDIAC ALLOGRAFT SURVIVAL AFTER TREATMENT WITH CYCLOSPORINE
SPECIFIC UNRESPONSIVENESS IN RATS WITH PROLONGED CARDIAC ALLOGRAFT SURVIVAL AFTER TREATMENT WITH CYCLOSPORINE
MOLECULAR COMPATIBILITY AND RENAL GRAFT SURVIVAL—THE HLA DQB1 GENOTYPING1
MOLECULAR COMPATIBILITY AND RENAL GRAFT SURVIVAL—THE HLA DRB1 GENOTYPING1
KIDNEY CELL-RESTRICTED RECOGNITION OF MHC CLASS I ALLOANTIGENS BY HUMAN CYTOLYTIC T CELL CLONES1
Day 230 After Transplant
CONFIRMATION OF GRAFT-VERSUS-HOST DISEASE AFTER LIVER TRANSPLANTATION BY PCR HLA-TYPING
SUCCESSFUL DONATION AND TRANSPLANTATION OF MULTIPLE ORGANS FROM A VICTIM OF CYANIDE POISONING
PARVOVIRUS B19 INFECTION CAUSING PURE RED CELL APLASIA IN A RECIPIENT OF PEDIATRIC DONOR KIDNEYS1
RAPID ANALYSIS OF TUMOR NECROSIS FACTOR-ALPHA mRNA EXPRESSION DURING VENOOCCLUSIVE DISEASE OF THE LIVER AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION1
LIVER TRANSPLANTATION FOR FAMILIAL HYPERCHOLESTEROLEMIA BEFORE THE ONSET OF CARDIOVASCULAR COMPLICATIONS
DIGESTIVE TRACT INFECTIONS IN KIDNEY AND LIVER TRANSPLANTATION IN A SINGLE INSTITUTION
THERAPEUTIC IN VIVO USE OF THE A1-CD3 MONOCLONAL ANTIBODY
REJECTION OF A KIDNEY GRAFT MISMATCHED ONLY FOR THE HLA-C LOCUS AND AN HLA-BW22 SPLIT
USE OF GREENFIELD FILTERS IN RENAL TRANSPLANT PATIENTS—ARE THEY SAFE?
DISSEMINATED INTRAVASCULAR COAGULATION IN CADAVERIC ORGAN DONORS INCIDENCE AND EFFECT ON RENAL TRANSPLANTATION
ABSENCE OF CLINICAL SYMPTOMS FOLLOWING THE FIRST INJECTION OF ANTI-T CELL RECEPTOR MONOCLONAL ANTIBODY (BMA 031) DESPITE ISOLATED TNF RELEASE
AN ALTERNATIVE TECHNIQUE FOR IN SITU ARTERIAL FLUSHING IN ELDERLY LIVER DONORS WITH ATHEROSCLEROTIC OCCLUSIVE DISEASE
USE OF EXTRACORPOREAL MEMBRANE OXYGENATION FOR ADULT RESPIRATORY DISTRESS SYNDROME FOLLOWING CADAVERIC RENAL TRANSPLANTATION
HIGH-DOSE ORAL ACYCLOVIR PROPHYLAXIS FOR PRIMARY CYTOMEGALOVIRUS INFECTION IN SERONEGATIVE RENAL ALLOGRAFT RECIPIENTS
OSMOTIC PUMP DELIVERY OF RAPAMYCIN
THE REGENERATION OF TRANSPLANTED HEPATOCYTES WITHIN THE MESENTERIC FAT PAD OF MICE
15-DEOXYSPERGUALIN EFFECTS IN RAT HEART ALLOGRAFT TRANSPLANTATION—RELATION TO DOSE, TIMING, AND CYCLOSPORINE1
PREVENTION OF REJECTION OF TRANSFORMING GROWTH FACTOR β-TREATED RAT-TO-MOUSE ISLET XENOGRAFTS BY MONOCLONAL ANTIBODY TO TUMOR NECROSIS FACTOR